In breast cancer, Nectin-4 and tyrosine kinase receptor ErbB2 (also known as Her2) are highly expressed and can cis-interact with each other to activate the PI3K/AKT signaling pathway for DNA synthesis (42). Here, NECTIN4 is linked to breast cancer.